PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · IEX Real-Time Price · USD
2.900
+0.180 (6.62%)
At close: Apr 18, 2024, 4:00 PM
2.950
+0.050 (1.72%)
Pre-market: Apr 19, 2024, 4:04 AM EDT
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $106.37 million as of April 19, 2024. Its market cap has decreased by -45.09% in one year.
Market Cap
106.37M
Enterprise Value
73.66M
1-Year Change
-45.09%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since October 1, 2015, PDS Biotechnology's market cap has decreased from $334.50M to $106.37M, a decrease of -68.20%. That is a compound annual growth rate of -12.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 106.40M | 6.61% |
Apr 17, 2024 | 99.80M | -2.82% |
Apr 16, 2024 | 102.70M | -0.68% |
Apr 15, 2024 | 103.40M | -11.62% |
Apr 12, 2024 | 117.00M | -5.34% |
Apr 11, 2024 | 123.60M | 7.01% |
Apr 10, 2024 | 115.50M | -3.67% |
Apr 9, 2024 | 119.90M | -1.24% |
Apr 8, 2024 | 121.40M | 2.45% |
Apr 5, 2024 | 118.50M | -1.82% |
Apr 4, 2024 | 120.70M | -10.59% |
Apr 3, 2024 | 135.00M | -1.03% |
Apr 2, 2024 | 136.40M | -7.53% |
Apr 1, 2024 | 147.50M | 1.58% |
Mar 28, 2024 | 145.20M | 21.20% |
Mar 27, 2024 | 119.80M | -14.06% |
Mar 26, 2024 | 139.40M | -5.23% |
Mar 25, 2024 | 147.10M | 2.37% |
Mar 22, 2024 | 143.70M | -5.34% |
Mar 21, 2024 | 151.80M | 1.47% |
Mar 20, 2024 | 149.60M | 2.54% |
Mar 19, 2024 | 145.90M | -1.35% |
Mar 18, 2024 | 147.90M | -2.95% |
Mar 15, 2024 | 152.40M | 2.35% |
Mar 14, 2024 | 148.90M | 0.74% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Alpha Teknova | 106.14M |
Vivani Medical | 105.56M |
Outset Medical | 105.05M |
Cartesian Therapeutics | 103.53M |
Xtant Medical Holdings | 102.78M |
Emergent BioSolutions | 101.80M |
Anixa Biosciences | 101.12M |
KORU Medical Systems | 100.13M |